The global ELISpot and FluoroSpot assay market is projected to reach an approximate value of USD 517.4 million by 2028, growing at a CAGR of 15.1%. Rise in prevalence of chronic diseases, increasing focus on vaccine development coupled rapid technological advancements are factors driving the ELISpot and FluoroSpot assay market.
Adroit Market Research report on global ELISpot and FluoroSpot assay market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 and 2019, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global ELISpot and FluoroSpot assay market have been studied in detail.
The ELISpot and FluoroSpot assays can basically be applied to investigate protein secretion at the single cell level. ELISpot assay allows visualization of the secretory product of individually activated or responding cells. The technique uses micro plates which are coated by antibodies on which sample cells are cultured. The antibodies arrest the specific molecules released by the activated cells. The FluoroSpot assay enables the simultaneous measurement of different analytes secreted at the single-cell level. This highly sensitive cellular assay is robust, easy to perform, and suitable for both single tests and large-scale screening. Increase in prevalence of chronic diseases will drive the demand for ELISpot and FluoroSpot assays in the next few years.
The global ELISpot and FluoroSpot assay market has been segmented based on product, application, end-users, and region. Based on product, the global ELISpot and FluoroSpot assay market is categorized into assay kits, analyzers, and ancillary products. Application-wise, the global ELISpot and FluoroSpot assay is segmented into diagnostic applications and research applications. On the basis of end-users, the global ELISpot and FluoroSpot assay market is segmented into hospitals & clinical laboratories, research institutes, and biotechnology companies.
North America dominated the global ELISpot and FluoroSpot assay market in 2019. High prevalence of infectious diseases in the U.S. and Canada, rising number of elderly patient pool, presence of well-established market players in the region are key factors likely to drive the growth of the market in the region. However, Asia Pacific ELISpot and FluoroSpot assay market is anticipated to grow at a rapid pace over the forecast period owing to increase in prevalence of chronic diseases along with surging R&D activities for vaccine development in the region.
Major players operating in the global ELISpot and FluoroSpot assay market include Oxford Immunotec, Cellular Technology Limited, BD, AID GmbH, Mabtech, Bio-Techne, Lophius Biosciences, Abcam, Biotech Investissement Group, and U-CyTech biosciences among others.
Key Segments of the Global ELISpot and FluoroSpot Assay Market
Product Type Overview, 2018-2028 (USD Million)
- Assay Kits
- Ancillary Products
Application Overview, 2018-2028 (USD Million)
- Diagnostic Applications
- Research Applications
End-users Overview, 2018-2028 (USD Million)
- Hospitals & Clinical Laboratories
- Research Institutes
- Biotechnology Companies
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa